Annual report [Section 13 and 15(d), not S-K Item 405]

Borrowings - Q2 2025 Notes (Details)

v3.26.1
Borrowings - Q2 2025 Notes (Details)
12 Months Ended
Apr. 03, 2025
USD ($)
D
$ / shares
Dec. 31, 2025
USD ($)
shares
Debt Instrument [Line Items]    
Net proceeds from issuance of convertible notes payable   $ 2,500,000
Q2 2025 Notes    
Debt Instrument [Line Items]    
Floor price (in $ per share) | $ / shares $ 0.1794  
Percentage of proceeds multiplied 105.00%  
Fair value of the convertible note $ 23,200,000  
Net proceeds from issuance of convertible notes payable 13,700,000  
Proceeds from issuance of convertible debt $ 9,500,000  
Change in fair value   $ 6,500,000
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]   Interest Expense
Original issuance amount   $ 1,700,000
Interest expense   1,300,000
Outstanding principal converted   $ 16,700,000
Number of shares issued upon conversion (in shares) | shares   66,288,407
Amount recorded to additional paid in capital   $ 22,400,000
Convertible notes   $ 0
Q2 2025 Notes | Investor    
Debt Instrument [Line Items]    
Original issue discount 10.00%  
Term of the notes 18 months  
Interest accrued $ 0  
Interest rate accrued event of default (%) 12.00%  
Debt instrument conversion price (in $ per share) | $ / shares $ 1  
Conversion price, percentage of average VWAPs considered (in %) 90.00%  
Conversion price number of lowest daily VWAPs considered | D 10  
Proceeds from future financings 30.00%  
Beneficial ownership limitations (in percent) 4.99%  
Amended maximum percentage of ownership post conversion upon written notice (%) 9.99%